Search by Drug Name or NDC
NDC 69102-0105-01 Levetiracetam 500 mg/1 Details
Levetiracetam 500 mg/1
Levetiracetam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by OWP Pharmaceuticals, Inc.. The primary component is LEVETIRACETAM.
MedlinePlus Drug Summary
Levetiracetam is used alone and along with other medications to control partial-onset seizures (seizures that involve only one part of the brain) in adults, children, and infants 1 month of age or older. Levetiracetam is also used in combination with other medications to treat seizure in adults and children 12 years of age or older with juvenile myoclonic epilepsy. Levetiracetam is also used in combination with other medications to treat primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 6 years of age or older with epilepsy. Levetiracetam is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.
Related Packages: 69102-0105-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Levetiracetam
Product Information
| NDC | 69102-0105 |
|---|---|
| Product ID | 69102-105_14899d4b-b295-431e-b1d5-d8163bdadb87 |
| Associated GPIs | 72600043000330 |
| GCN Sequence Number | 044633 |
| GCN Sequence Number Description | levetiracetam TABLET 500 MG ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 41597 |
| HICL Sequence Number | 020952 |
| HICL Sequence Number Description | LEVETIRACETAM |
| Brand/Generic | Generic |
| Proprietary Name | Levetiracetam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Levetiracetam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/1 |
| Substance Name | LEVETIRACETAM |
| Labeler Name | OWP Pharmaceuticals, Inc. |
| Pharmaceutical Class | Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078858 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69102-0105-01 (69102010501)
| NDC Package Code | 69102-105-01 |
|---|---|
| Billing NDC | 69102010501 |
| Package | 120 TABLET in 1 BOTTLE (69102-105-01) |
| Marketing Start Date | 2020-10-28 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.09468 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | ROWEEPRA 500 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |